Harrow Health Company Insiders

HROW Stock  USD 43.88  1.44  3.39%   
Harrow Health's insiders are aggressively buying. The analysis of insiders' sentiment of trading Harrow Health stock suggests that vertually all insiders are extremely bullish at this time. Harrow Health employs about 315 people. The company is managed by 14 executives with a total tenure of roughly 735 years, averaging almost 52.0 years of service per executive, having 22.5 employees per reported executive.

Harrow Health's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2024-04-25Opaleye Management Inc.Acquired 20000 @ 9.97View
2024-04-23Opaleye Management Inc.Acquired 11715 @ 10.29View
2024-04-19Opaleye Management Inc.Acquired 29400 @ 10.56View
2024-03-28Opaleye Management Inc.Acquired 50000 @ 12.82View
2024-03-22Mark L BaumAcquired 9000 @ 11.59View
2024-03-20Opaleye Management Inc.Acquired 50600 @ 9.65View
Monitoring Harrow Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Harrow Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Harrow Health's future performance. Based on our forecasts, it is anticipated that Harrow will maintain a workforce of slightly above 320 employees by December 2024.
 
Credit Downgrade
 
Yuan Drop
 
Covid

Harrow Health Management Team Effectiveness

The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5023) %, meaning that it created substantial loss on money invested by shareholders. Harrow Health's management efficiency ratios could be used to measure how well Harrow Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 0 in 2024, whereas Return On Tangible Assets are likely to drop (0.17) in 2024. At this time, Harrow Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 146 M in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (2 M).
Common Stock Shares Outstanding is likely to climb to about 34.2 M in 2024, despite the fact that Net Loss is likely to grow to (12 M).

Harrow Health Workforce Comparison

Harrow Health is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 827. Harrow Health totals roughly 315 in number of employees claiming about 38% of equities under Health Care industry.

Harrow Health Profit Margins

The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.470.6955
Way Down
Slightly volatile

Harrow Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harrow Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harrow Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Harrow Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.5
1
2
 90,000 
 135,140 
2024-03-01
1.2222
11
9
 368,638 
 343,732 
2023-12-01
1.5
3
2
 52,500 
 29,778 
2023-09-01
1.1667
7
6
 1,431,800 
 1,931,398 
2023-06-01
4.0
8
2
 1,596,976 
 297,633 
2023-03-01
0.5
3
6
 201,000 
 280,223 
2022-09-01
2.0
2
1
 11,085 
 40,000 
2022-03-01
0.8333
5
6
 231,343 
 342,934 
2021-09-01
5.0
15
3
 1,531,001 
 23,900 
2021-06-01
2.0
10
5
 1,090,660 
 1,371,461 
2021-03-01
1.6667
5
3
 455,000 
 237,500 
2020-09-01
1.6667
10
6
 355,298 
 93,798 
2020-06-01
15.0
15
1
 778,924 
 600,000 
2020-03-01
0.75
6
8
 467,718 
 457,719 
2019-12-01
0.5
2
4
 195,000 
 208,000 
2019-06-01
1.3333
4
3
 38,860 
 30,000 
2019-03-01
1.6667
5
3
 350,000 
 30,000 
2018-03-01
2.5
5
2
 310,000 
 60,000 
2017-06-01
2.3333
7
3
 317,892 
 255,000 
2017-03-01
4.0
4
1
 322,000 
 20,000 
2016-12-01
4.0
8
2
 885,000 
 283,709 
2016-06-01
5.0
10
2
 1,570,950 
 1,207,500 
2016-03-01
4.0
4
1
 150,000 
 15,000 
2015-06-01
2.3333
7
3
 78,207 
 425,282 
2015-03-01
2.0
4
2
 307,500 
 25,000 
2014-09-01
2.0
6
3
 98,367 
 90,465 
2012-12-01
0.5
1
2
 38,014 
 0.00 
2012-09-01
1.0
7
7
 6,371,623 
 15,979,883 
2012-06-01
2.0
14
7
 23,285,286 
 778,812 
2012-03-01
0.6667
8
12
 3,133,261 
 13,266,761 
2011-12-01
0.25
1
4
 493.00 
 4,928 
2009-12-01
1.0
1
1
 215,000 
 85,000 
2008-12-01
5.0
5
1
 290,000 
 10,000 
2008-09-01
3.5
7
2
 7,900 
 20,000 
2008-06-01
3.0
3
1
 304,200 
 300,000 

Harrow Health Notable Stakeholders

A Harrow Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Harrow Health often face trade-offs trying to please all of them. Harrow Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Harrow Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
CMA CFACFO SecretaryProfile
Robert DDSSpecial AdvisorProfile
Jamie WebbDirector RelationsProfile
David MoufarrgeVP TechnologyProfile
RPh MannebachHead PharmacovigilanceProfile
Brett BurrellVice ComplianceProfile
CFA CMACFO SecProfile
Andrew LivingstonChief OfficerProfile
Larry MDChief OfficerProfile
Mark JDCEO ChairmanProfile
Kim BarrattChief OfficerProfile
Greg DiPasqualeSenior CommercialProfile
John MBAChief OfficerProfile
Dennis PharmDChief StrategyProfile

About Harrow Health Management Performance

The success or failure of an entity such as Harrow Health often depends on how effective the management is. Harrow Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Harrow management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Harrow management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.16)(0.17)
Return On Assets(0.08)(0.08)
Return On Equity(0.35)(0.36)
Please note, the imprecision that can be found in Harrow Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Harrow Health. Check Harrow Health's Beneish M Score to see the likelihood of Harrow Health's management manipulating its earnings.

Harrow Health Workforce Analysis

Traditionally, organizations such as Harrow Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Harrow Health within its industry.

Harrow Health Manpower Efficiency

Return on Harrow Health Manpower

Revenue Per Employee413.3K
Revenue Per Executive9.3M
Net Loss Per Employee77.5K
Net Loss Per Executive1.7M
Working Capital Per Employee286.2K
Working Capital Per Executive6.4M

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.